The primary objective of this position will be responsible for managing US pipeline price forecasting. This involves supporting the translation of the value in our assets & indications into optimal launch pricing, across AbbVie’s early to late-stage pipeline assets. They will be responsible for aligning with the USMAx pipeline market access organization and shall also work within a cross-functional matrix of stakeholders for their Brands/Indications to ensure effective shaping of the price potential of our assets, through utilization of our strategic pricing approach and advanced modelling techniques. They are also responsible for driving key scenario analysis such as Gross to Net optimization, Policy impact (IRA/MFN) on pricing, Price Volume Time Tradeoffs and indication sequencing during BD assessments, LRP & off-cycle Governances. This position is a full-time role that reports to the Director, PCS Price Forecasting, in US Strategic Pricing org.

Responsibilities

• Serve as a subject matter expert and guide cross-functional teams on U.S. pricing, market access, reimbursement, and Inflation Reduction Act (IRA) considerations by therapeutic area to objectively assess and communicate their impact on U.S. gross and net pricing
• Independently manage pipeline assets and business development evaluations for designated therapeutic areas with minimal guidance
• Build trusted partnerships with key stakeholders and act as a strategic thought partner
• Evaluate & integrate new pricing approaches to inform and shape pipeline asset price potential and implications, by proactively engaging, contributing and liaising with key cross functional partners (USMAx Pipeline, MABI, Finance, BD, Commercial)
• Define pricing hypothesis, and conduct scenario analysis, supporting the development of pricing guidance, in collaboration with USMAx Pipeline, MABI, Finance and other relevant key stakeholders.
• Provide input and guidance on the pricing potential for business development (BD) opportunities by undertaking rapid assessments with the best available data to identify the risks and opportunities that may affect the final asset valuation
• Responsible for collaborating with USMAx Pipeline TA & MABI to support primary and secondary pricing market research using appropriate methodologies aligned with a Strategic Pricing approach
• Coordinating and ensuring appropriate review and approval of BD, early price & pricing guidance across their Brands and indications for preparation of review with Executive Leadership
• Provide accurate and timely pricing information, across pricing and finance processes (LRP) including harmonization and collation of pricing assumptions, creation of price models, coordination of touchpoints with TA team & leadership briefing presentations
• Ad Hoc pricing analytics, such as but not limited to; external price benchmarking, gross to net analysis, IRA economics etc.